Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Nuvectis Pharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −9 vs. Q2 2024
- Shares held
- 1.05M
- −72.3K (−6.4%) vs. Q2 2024
- Total value
- $6.60M
- −$499.5K (−7.0%) vs. Q2 2024
- New holders
- 4
- 9 more added
- Sold out
- 13
- 11 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 11 | $69 | 0.00% | −2−15.4% | Reduced |
| Nisa Investment Advisors, LLC | 12 | $75 | 0.00% | −200−94.3% | Reduced |
| Steward Partners Investment Advisory, LLC | 100 | $629 | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 192 | $1.21K | 0.00% | −14,561−98.7% | Reduced |
| Hollencrest Capital Management | 280 | $1.76K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 402 | $2.53K | 0.00% | −569−58.6% | Reduced |
| Tower Research Capital LLC (TRC) | 588 | $3.70K | 0.00% | −5,408−90.2% | Reduced |
| Bank of America Corp | 760 | $4.78K | 0.00% | −4−0.5% | Reduced |
| Catalyst Funds Management Pty Ltd | 900 | $5.66K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,144 | $7.20K | 0.00% | −7,126−86.2% | Reduced |
| Morgan Stanley | 2,348 | $14.8K | 0.00% | −7,850−77.0% | Reduced |
| Citigroup Inc | 8,887 | $55.9K | 0.00% | +4,004+82.0% | Added |
| Nations Financial Group Inc, | 10,000 | $62.9K | 0.00% | +10,000 | New |
| Baxter Bros Inc | 12,500 | $78.6K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 15,253 | $95.9K | 0.00% | −34,574−69.4% | Reduced |
| State Street Corp | 15,300 | $96.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,800 | $99.4K | 0.00% | −58,700−78.8% | Reduced |
| Edmond de Rothschild Holding S.A. | 19,170 | $120.6K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 22,433 | $141.1K | 0.00% | +14,455+181.2% | Added |
| Susquehanna International Group, LLP | 26,463 | $166.5K | 0.00% | +26,463 | New |
| Two Sigma Investments, LP | 26,785 | $168.5K | 0.00% | +13,741+105.3% | Added |
| Marshall Wace, LLP | 42,814 | $269.3K | 0.00% | +8,946+26.4% | Added |
| Forbes J M & Co LLP | 48,401 | $304.4K | 0.03% | +982+2.1% | Added |
| BlackRock, Inc. | 49,554 | $311.7K | 0.00% | +49,554 | New |
| Gsa Capital Partners LLP | 50,129 | $315.0K | 0.02% | +1,790+3.7% | Added |
| Iridian Asset Management LLC | 55,380 | $348.3K | 0.07% | +55,380 | New |
| Millennium Management LLC | 68,499 | $430.9K | 0.00% | −50,960−42.7% | Reduced |
| Geode Capital Management, LLC | 79,716 | $501.5K | 0.00% | +26,489+49.8% | Added |
| Baldwin Brothers Inc | 174,130 | $1.10M | 0.07% | +5,500+3.3% | Added |
| Vanguard Group Inc | 301,138 | $1.89M | 0.00% | +50,000+19.9% | Added |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −61,570−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −23,173−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,021−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,937−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,627−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −9,203−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −3,254−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −1,871−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,249−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |